TJ Chao, PA-C: Considering Adverse Events in Patients with Atopic Dermatitis
TJ Chao breaks down the black box warnings for ruxolitinib cream 1.5% and discusses the importance in communicating the specifics of these warnings to patients.
Raj Chovatiya, MD: Key Ingredients in Moisturizers for Atopic Dermatitis
Dr. Chovatiya reviews some of the essentials to look for in moisturizers such as a treatment that is semipermeable and has natural moisturizing factors.
Emma Guttman-Yassky, MD, PhD: Pushing the Boundaries of Atopic Dermatitis Treatment Efficacy
James Del Rosso, DO: What’s New and Hot in Acne and Rosacea
Nada Elbuluk, MD: New Research on Psychological Comorbidities in Patients with Vitiligo
Dr. Elbuluk discusses a recently published retrospective chart review that she and her colleagues published in the Archives of Dermatological Research, which included all patients diagnosed with vitiligo treated at a private hospital and a public hospital over a period of ten years, with a focus on associated psychiatric comorbidities. She summarizes the findings of rates of anxiety and depression in patients with vitiligo in terms of gender, race, and socioeconomic status.